![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oak-hill-bio-and-chiesi-group-announce-first-patient-enrolled-in-the-resumed-phase-2b-clinical-study-evaluating-ohb-607-for-the-prevention-of-bronchopulmonary-dysplasia-the-most-common-cause-of-chronic-lung-disease-in-premature-i-302148908.html
https://www.pharmiweb.com/press-release/2024-05-15/chiesi-group-forges-alliance-with-karolinska-institutet-to-tackle-urgent-health-challenges
https://www.fiercepharma.com/manufacturing/sanofi-pfizer-astrazeneca-invest-combined-2b-bolster-operations-france
https://www.reuters.com/business/healthcare-pharmaceuticals/gossamer-bio-chiesi-group-collaborate-blood-pressure-treatment-2024-05-06/
https://www.pharmaceutical-technology.com/news/gossamer-bio-chiesi-pah/
https://www.pharmaceutical-technology.com/news/chiesi-champions-new-inhaler-propellant-to-reduce-carbon-footprint/
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-presents-long-term-data-on-treatment-with-velmanase-alfa-in-alpha-mannosidosis-and-announces-additional-presentations-at-the-20th-annual-worldsymposium-research-meeting-302058140.html